Preclinical Testing in the Development of Probiotics: A Regulatory Perspective with Bacillus Strains as an Example
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Preclinical testing of the microbial strains is the first important step in the development of probiotics. Requirements for the set of tests can vary depending on the bacterial species and the expected mechanism of action in the organism. Common approaches to preclinical testing of probiotic strains include strain identification (i.e., determination of phenotypic and genotypic properties), safety evaluation (i.e., characterization of history of use [safety contact], assessment of resistance to antibiotics, and evaluation of pathogenic properties in vitro and in animal models), and efficacy testing (i.e., functional characterization). Future progress in probiotics requires more studies to determine the mechanisms of their action, as well as an understanding of the basis and mechanisms of pathogenicity for different probiotic strains. Special attention should be given to recombinant probiotics, particularly in the formulation of criteria for selection of the host strain, for assessment of environmental safety, and for tracing the fate of recombinant DNA in vitro and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testing for the probiotic potential of various microorganisms starts at the preclinical level and includes evaluations of antibiotic resistance, safety and potential efficacy132”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [132]
Citations
Cites
The use of bacterial spore formers as probiotics: Table 1
Hong, H. A., Duc, L. H., & Cutting, S. M. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.001 · Cited by 975
Identification and antibiotic susceptibility of bacterial isolates from probiotic products
Temmerman, R., Pot, B., Huys, G., & Swings, J. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00162-9 · Cited by 500
Ishibashi, N., & Yamazaki, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.465s · Cited by 352
The Intestinal Life Cycle of Bacillus subtilis and Close Relatives
Tam, N. K. M., Uyen, N. Q., Hong, H. A., Duc, L. H., Hoa, T. T., Serra, C. R., Henriques, A. O., & Cutting, S. M. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2692-2700.2006 · Cited by 334
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
Lactobacilli as live vaccine delivery vectors: progress and prospects
Seegers, J. F. M. L. (2002) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)02075-9 · Cited by 225
Antimicrobial susceptibility of bifidobacteria
Moubareck, C., Gavini, F., Vaugien, L., Butel, M. J., & Doucet-Populaire, F. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh495 · Cited by 199
The Importance of Guidelines in the Development and Application of Probiotics
Reid, G. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382395 · Cited by 180
Beattie, S. H., & Williams, A. G. (1999) · Letters in Applied Microbiology · doi:10.1046/j.1365-2672.1999.00498.x · Cited by 149
Research works printed but not linked: 8
- Smirnov VV, 1994, Antibiot Khimioter, 39, 23
- Donohue DC, 2006, Asia Pac J Clin Nutr, 15, 563
- Osipova IG, 1998, Zh Mikrobiol Epidemiol Immunobiol, 6, 68
- Momose H, 1979, Appl Pharmacol, 17, 881
- Urdaci MC, 2004, United Kingdom: Horizon Bioscience, 171
- Sorokulova IB, 1997, Mikrobiol Z, 59, 43
- Furzikova TM, 2000, Mikrobiol Z, 62, 26
- Sorokulova IB, 1997, Vestn Ross Akad Med Nauk, 3, 46
Cited by
Postbiotics: An Evolving Term within the Functional Foods Field
Aguilar-Toalá, J. E., Garcia-Varela, R., Garcia, H. S., Mata-Haro, V., González-Córdova, A. F., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.03.009 · Cited by 1,078
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Safety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
Probiotics from research to market: the possibilities, risks and challenges
Foligné, B., Daniel, C., & Pot, B. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.008 · Cited by 195
Application of probiotics in food products—challenges and new approaches
Jankovic, I., Sybesma, W., Phothirath, P., Ananta, E., & Mercenier, A. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.03.009 · Cited by 172
Sikorska, H., & Smoragiewicz, W. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.003 · Cited by 172
Identification of Bacillus Strains for Biological Control of Catfish Pathogens
Ran, C., Carrias, A., Williams, M. A., Capps, N. K., Dan, B. C. T., Newton, J. C., Kloepper, J. W., Ooi, E. L., Browdy, C. L., Terhune, J. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045793 · Cited by 143
Kechaou, N., Chain, F., Gratadoux, J.-J., Blugeon, S., Bertho, N., Chevalier, C., Le Goffic, R., Courau, S., Molimard, P., Chatel, J. M., et al. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03075-12 · Cited by 113
Spore-forming bacteria and their utilisation as probiotics
Bader, J., Albin, A., & Ståhl, U. (2012) · Beneficial Microbes · doi:10.3920/bm2011.0039 · Cited by 106
Giardia spp. and the Gut Microbiota: Dangerous Liaisons
Fekete, E., Allain, T., Siddiq, A., Sosnowski, O., & Buret, A. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.618106 · Cited by 86
Anti-influenza Activity of a Bacillus subtilis Probiotic Strain
Starosila, D., Рыбалко, С. Л., Varbanetz, L., Ivanskaya, N. V., & Sorokulova, I. B. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00539-17 · Cited by 87
Self-citationSoares, M. B., de Almada, C. N., Pereira, E. P. R., Ferreira, B. M., Balthazar, C. F., Khorshidian, N., Rocha, R. S., Xavier-Santos, D., da Cruz, A. G., Ranadheera, C. S., et al. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.06.029 · Cited by 92
Horosheva, T. V., Vodyanoy, V., & Sorokulova, I. (2014) · JMM Case Reports · doi:10.1099/jmmcr.0.004036 · Cited by 57
“Both Bacillus strains have been thoroughly tested in preclinical testing (Pinchuk et al., 2001; Sorokulova, 2008; Abbreviations: AAD, antibiotic-associated diarrhoea; ARR, absolute risk reduction; CI, confidence interval; CDD, Clostridium difficile-associated diarrhoea; OR, odds ratio; RR, relative…”
BackgroundSelf-citationNath, A., Molnár, M. A., Csighy, A., Kőszegi, K., Galambos, I., Pásztor‐Huszár, K., Koris, A. K., & Vatai, G. N. (2018) · Medicina · doi:10.3390/medicina54060098 · Cited by 60
Foligné, B., Peys, E., Vandenkerckhove, J., hemel, J. V., Dewulf, J., Breton, J., & Pot, B. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.05.016 · Cited by 55
Zhou, D. B., Zhu, Y., Zhang, W., Wang, M., Fan, W.-Y., Song, D., Yang, G., Jensen, B. B., & Wang, J. (2015) · Veterinary Research · doi:10.1186/s13567-015-0223-y · Cited by 48
Hamdy, A. A., Elattal, N. A., Amin, M. A., Ali, A. E., Mansour, N. M., Awad, G. E. A., Awad, H. M., & Esawy, M. A. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2231-8 · Cited by 48
Antagonistic Activity of Bacillus Bacteria against Food-Borne Pathogens
Moore, T. (2013) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000110 · Cited by 45
Shobharani, P., & Halami, P. M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5981-3 · Cited by 42
Scalfaro, C., Iacobino, A., Nardis, C., & Franciosa, G. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx064 · Cited by 39
Soares, M. B., de Almada, C. N., de Almada, C. N., Martinez, R. C. R., Pereira, E. P. R., Balthazar, C. F., da Cruz, A. G., Ranadheera, C. S., & Sant’Ana, A. S. (2019) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2019.108288 · Cited by 39
The use of probiotics and safety concerns: A review
Suresh Babu Naidu, K., Jamila, K. A., & Govender, P. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr12.1281 · Cited by 33
Important role of Bacillus subtilis as a probiotic and vaccine carrier in animal health maintenance
Yuan, C., Ji, X., Zhang, Y., Liu, X., Ding, L., Li, J., Ren, S., Liu, F., Chen, Z., Zhang, L., et al. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04065-0 · Cited by 21
Silva, M. P., Rossoni, R. D., Junqueira, J. C., & Jorge, A. O. C. (2016) · InTech eBooks · doi:10.5772/64093 · Cited by 18
Sporolactobacillus—a new functional genus with potential applications
Guo, X., Yu, L., Xiao, M., Zang, X., Zhang, C., Narbad, A., Chen, W., Tian, F., & Zhai, Q. (2024) · Current Research in Food Science · doi:10.1016/j.crfs.2024.100822 · Cited by 14
Recombinant Probiotics: Future Perspectives in Disease Treatment
Sorokulova, I. B. (2014) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000e109 · Cited by 10
Self-citationSantos, S. S., de Souza, M. B., Lauria, P. S. S., Juíz, P. J. L., Villarreal, C. F., & Viana, M. D. M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230522121707 · Cited by 8
Біологічна активність пробіотичних штамів бацил – основи препарату ендоспорину
Сафронова, Л. А. (2016) · Reports of the National Academy of Sciences of Ukraine · doi:10.15407/dopovidi2015.06.138 · Cited by 4
Biosynthetic Activity of Bacilli, Stipulated Their Probiotic Effect
Сафронова, Л. А., & Iliash, V. M. (2017) · Mikrobiolohichnyi Zhurnal · doi:10.15407/microbiolj79.06.120 · Cited by 4
Probiotic Effects on Disease Prevention and Treatment
Farahmandi, K., & Sulaimany, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.109717 · Cited by 6
Chen, B., Tang, Y., Huang, L., Wang, Z., Li, J., Zhang, M., Yang, Y., Zhang, D., Jing, B., Zeng, Y., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10720-1 · Cited by 2
Zebrafish: A novel model organism to assess probiotics influence on growth and development
Rajakumari, D., Viswanath, B., & Rani, A. U. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821406-0.00029-1 · Cited by 3
Evaluation of Biological Agents for Controlling Enteric Septicemia of Catfish
Carrias, A. (2011) · Cited by 3
Probiotics, with special emphasis on their role in the management of irritable bowel syndrome
Stevenson, C., & Blaauw, R. (2012) · Pharmacy management
(2016) · CRC Press eBooks · doi:10.1201/9781315372129-16
Tutun, S., Demir, T., Can, Ö. P., & Erol, Z. (2026) · Revista Científica de la Facultad de Ciencias Veterinarias · doi:10.52973/rcfcv-e3631034
Metadata
- Authors
- Sorokulova, I.
- Affiliations
- National Academy of Sciences of Ukraine (UA)
- Corresponding author
- Sorokulova, Iryna
- ORCID
- Sorokulova, Iryna
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 46
- Issue
- s2
- Pages
- S92-S95
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2119190439
- Cited by
- 38
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 6
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- General Mills
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
- Keywords
- probiotics, preclinical testing, regulatory requirements, strain identification, safety assessment, antibiotic resistance, pathogenicity, efficacy evaluation, recombinant probiotics, host strain selection, environmental safety, mechanism of action
- MeSH terms
- Animals, Bacillus, Bacteria, Consumer Product Safety, Drug Evaluation, Preclinical, Humans, Probiotics, Drug Resistance, Bacterial, Government Regulation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.